phar.kindai.ac.jp
Practice of Clinical Pharmacotherapy（4th）
Hospital and Community Rotations（4th）
Early Exposure to Pharmacy Profession（1st）
Drug Information Practice 1 (1st)
Drug Information Practice 2（1st）
Staff |
|
Professor Mitsutaka Takada
takadaphar.kindai.ac.jp |
|
|
Drug Information 2（3rd） Practice of Clinical Pharmacotherapy（4th） Hospital and Community Rotations（4th） Early Exposure to Pharmacy Profession（1st） Drug Information Practice 1 (1st) Drug Information Practice 2（1st） |
|
Associate Professor Takeshi Kimura
t.kimuraphar.kindai.ac.jp |
|
 |
Drug Information 2（3rd） Practice of Clinical Pharmacotherapy（4th） Hospital and Community Rotations（4th） Early Exposure to Pharmacy Profession（1st） Drug Information Practice 1 (1st) Drug Information Practice 2（1st） |
|
Lecturer Tohru Ohtori
tohtoriphar.kindai.ac.jp |
|
 |
Introductory Pharmaceutical Sciences 2（4th） Practice of Clinical Pharmacotherapy (4th) Hospital and Community Rotations (4th) Early Exposure to Pharmacy Profession (1st) Drug Information Practice 1(1st) Drug Information Practice 2(1st) TD> |
|
Lecturer Shunji Ishiwata
ishiwataphar.kindai.ac.jp |
||
 |
Dispensing Pharmacy（3rd） Scientific Reading in English 2（3rd） Practice of Clinical Pharmacotherapy（4th） Hospital and Community Rotations（4th） | |
|
Lecturer Manabu Kitakouji m-kitakphar.kindai.ac.jp |
||
 |
Hygiene Chemistry (3rd) Practice of Hygenic Pharmacy (3rd) Practice of Clinical Pharmacotherapy（４th） | |
|
Assistant Hiroko hachiken
hhachiphar.kindai.ac.jp |
|
 |
Practice of Clinical Pharmacotherapy (4th) Hospital and Community Rotations (4th) Early Exposure to Pharmacy Profession (1st) Drug Information Practice 1 (1st) Drug Information Practice 2 (1st) |
| Concurrent Lecturer Hiroyuki Kuwano Department of pharmacy, Kinki University Hospital |
| Concurrent Lecturer Kenichi Nakashima Department of pharmacy, Kinki University Hospital |
| Concurrent Lecturer Tetsuya Morita Department of pharmacy, Kinki University Sakai Hospital |
| Concurrent Lecturer Sadanobu Tachibana Department of pharmacy, Kinki University Nara Hospital |
１． Pharmacoepidemiology (Drug use, Side effect, Drug interaction) ２． Rational use of drugs ３． Drug data base ４． Pharmacokinetics ５． Pharmacy practice
There is a growing interest in medication error prevention and safe medication use. Pharmacotherapy plays an important role in current medical care due to the increasing need to better understand drug interactions and metabolism. The frequency of medication errors and adverse drug effects can be counted among the most common medical errors. With this in mind, pharmacists are expected to contribute to the safety and effective application of their pharmacotherapy expertise. The key word is "rational use of drugs". However, it is very difficult to find out whether drugs are rationally used in the clinical setting. It is not uncommon for drugs to be used off-label in clinical practice. In other words, medications are usually prescribed for a medical use other than the one approved by the pharmaceutical affairs law. In addition, the approved regimen of a drug might not be necessarily followed. The risks and benefits are inextricably linked in pharmacotherapy. The use of drugs with minimal risk and increased benefit to the patient is strongly urged in the current medical care setting. The cultivation of highly qualified pharmacists is strongly desired. Our goal is to provide the necessary training to our pharmacists to properly apply the “rational use of drugs” principle. Our division focuses on important issues such as clinical data gathering and analysis in order to better understand drug use and to verify the outcome in pharmacotherapy.
2006
1. Kyoichi Wada, Mitsutaka Takada, Takashi Ueda, Hiroyuki Ochi, Hideki Morishita, Akihisa Hanatani, Takeshi Nakatani: Pharmacokinetic study and limited sampling strategy of cyclosporine in Japanese heart transplant recipients. Circ J 70, 1307-1311, 2006.
2. Makoto Saito, Daisuke Nakayama, Mitsutaka Takada, Keiji Hirooka, Yoshio Yasumura: Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. J Clin Pharm Ther 31, 535-540, 2006.
3. Takeshi Kotake, Mitsutaka Takada, Kazuo Komamura, Shiro Kamakura, Kunio Miyatake, Masafumi Kitakaze, Hideki Morishita: Heart failure elevates the serum levels of cibenzolinein in the arrhythmic patients. Circ J 70, 588-592, 2006.
4. Takeshi Kotake, Mitsutaka Takada, Takuya Goto, Kazuo Komamura, Hideki Morishita: Serum amiodarone and desethylamiodarone concentrations in nasogastrically versus orally administered patients. J Clin Pharm Ther 31, 237-243, 2006.
2005
1. Takada M, Goto T, Kotake T, Saito M, Kawato N, Nakai M, Gunji T, Shibakawa M, Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring. J. Clin. Pharm. Ther., 30, 5-12 (2005).
2. Takada M, Okada H, Kotake T, Kawato N, Saito M, Nakai M, Gunji T, Shibakawa M,?Appropriate dosing regimen of allopurinol in Japanese patients. J. Clin. Pharm. Ther., 30, 407-412 (2005).
Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y, Serum concentration of potassium in chronic heart failure patients administered pironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. J. Clin. Pharm. Ther., 30, 603-610 (2005).
2004
1. Kimura T, Arai M, Masuda H, Kawabata A, Impact of pharmacist-implemented anemia management in outpatients with end-stage renal disease in Japan. Biol.Pharm.Bull., 27, 1831-1833 (2004).
2. Takada M, Fukumoto K, Shibakawa M, Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs. J. Clin. Pharm. Ther., 29, 183-187 (2004).